18 F-FDG Positron Emission Tomography (PET) is used to monitor tumor response to 131 I-therapy, but is confounded by prompt emissions (284, 364, 637, and 723 keV) from 131 I, particularly in animal PET imaging. We propose a method for correcting this emission in 18 F-FDG PET. The 131 I prompt emission effect was assessed within various energy windows and various activities. We applied a single gamma correction method to a phantom and in vivo mouse model. The 131 I prompt emission fraction was 12% when 300 µCi of 131 I and 100 µCi of FDG were administered, and increased exponentially with escalating 131 I activity for all energy windows. The difference in spill-over ratio was reduced to <5% after 131 I prompt emission correction. In the mouse model, the standard uptake value (SUV) did not differ significantly between FDG PET only (gold standard) and FDG PET after 131 I prompt emission-correction, whereas it was overestimated by 38% before correction. Contrast was improved by 18% after 131 I prompt emission correction. We first found that count contamination on 18 F-FDG follow-up scans due to 131 I spilled-over count after 131 I rituximab tumor targeted therapy. Our developed 131 I prompt emission-correction method increased accuracy during measurement of standard uptake values on 18 F-FDG PET.
Introduction
Radioimmunotherapy (RIT), such as 131 I labelled tositumomab (Bexxar) and 131 I labelled rituximab [1, 2] , is used for targeted treatment of cancer and involves selective delivery of radionuclidelabelled monoclonal antibodies (mAbs) [1, 3] . Imaging mAb using Positron Emission Tomography (PET) or Single-photon emission computed tomography (SPECT) was applied to quantitatively estimate expression of accessible antigens in the target tissue [4] [5] [6] . A gamma camera or SPECT imaging was used for 131 I imaging [7] . A conventional gamma camera is limited in terms of detection of differentiated thyroid carcinoma, owing to the biokinetics in the lesion and background in individual patients [8] . 124 I PET has been used to image the residual thyroid lesion after 131 I thyroid therapy [9] and can provide the dosimetry data for the activity of 131 I administered for therapy of differentiated thyroid cancer [10] . The 124 I PET-based response rates of small lymph node metastases and thyroid remnants in a minimum high-absorbed radiation dose group matched the histological data after administration 637 keV (7.16%)) from 131 I. This phenomenon is particularly prominent during animal PET, because wider energy windows, such as 250-750 keV or 350-750 keV, are used to increase the sensitivity of animal PET imaging. The high energy of the most abundant gammas can cause down scatter issues within the energy window of the 511 keV annihilation photons of PET imaging. Whether the low energy due to 131 I could also contaminate 18 F-FDG PET scans is unknown. The effect of 131 I prompt emission required assessment, because 364 keV and 637 keV emissions from gamma photons are within the conventional PET acquisition energy windows. During a 18 F-FDG follow-up study, we should check the possibility of inclusion of 131 I within PET acquisition.
The motivation of our study was the necessity of a quantification method of 18 F-FDG PET during 131 I therapy. To the best of our knowledge, there has been no report on the assessment of 131 I prompt emission or the development of 131 I prompt emission-correction for 18 F-FDG PET imaging. Our data showed that our 131 I prompt emission-correction method was feasible for use in 18 F-FDG follow-up after 131 I therapy in a preclinical study.
This study aimed to assess the count contamination on 18 F-FDG follow-up scans due to 131 I spill-over count after 131 I rituximab tumor targeted therapy. We measured the effect of 131 I prompt emission with various activity levels and energy windows using a phantom and animal model. We found count contamination on 18 F-FDG follow-up scans due to 131 I spill-over count after 131 I rituximab tumor targeted therapy. To limit this contamination, we developed the 131 I prompt emission correction method during 18 F-FDG PET.
Materials and Methods
In this study, we identified the effect of 131 I therapy during FDG PET scanning. For this purpose, we performed GATE Monte Carlo simulation, phantom study, and actual in vivo study using lymphoma mouse model. All mice-related experiments were performed under a protocol approved by IACUC (number KIRAMS 2013-104, date of approval: 6 January 2014) of the Korea Institute of Radiological and Medical Sciences (KIRAMS). Figure 1A shows a schematic illustration of PET emissions, such as true, scatter, and random emissions during annihilation. Figure 1B shows the prompt emissions due to 131 I. 131 I emitted 284, 364, 637, and 723 keV gamma rays. We previously developed a method for correction of 124 I single gamma ray emissions, such as those at 622 and 723 keV [18, 19] . 124 I prompt emissions create background Diagnostics 2019, 9, 144 3 of 10 noise [20] (shown in Figure 2 in [20] ). The characteristics of 131 I prompt emissions were similar to those of 124 I. Therefore, 131 I prompt emissions were also distributed as background noise ( Figure 1C ). A Siemens Inveon PET scanner (Siemens, Erlangen, Germany) was used for monitoring. Figure 2A . The value between "450 and 650 keV" and "450 and 750 keV" was not discernible in the scale of Kcounts/sec in Figure 2A . Therefore, we rescaled the Y-axis for the visibility of "450-650 keV" and "450-750 keV" in Figure 2B .
131 I Prompt Emissions during PET

GATE Simulation
We calculated the fraction of 131 I prompt emissions due to 131 I by GATE simulation, with various energy windows and various activity levels. We applied our 131 I prompt emission-correction method to 18 F-FDG PET in both a phantom and animal study.
Estimation of Prompt Emission Counting Rate due to A Single Gamma Photon from 131 I
The prompt emission counting rate was estimated using GATE simulation. The prompt emission due to 131 I would increase with increasing activities of 131 I. Therefore, activities were set from 100 µCi to 1000 µCi in steps of 100 µCi. The energy windows were 250-650 keV, 250-750 keV, 350-650 keV, Figure 2A . The value between "450 and 650 keV" and "450 and 750 keV" was not discernible in the scale of Kcounts/sec in Figure 2A . Therefore, we rescaled the Y-axis for the visibility of "450-650 keV" and "450-750 keV" in Figure 2B .
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Estimation of Prompt Emission Counting Rate due to A Single Gamma Photon from 131 I
The prompt emission counting rate was estimated using GATE simulation. The prompt emission due to 131 I would increase with increasing activities of 131 I. Therefore, activities were set from 100 µCi to 1000 µCi in steps of 100 µCi. The energy windows were 250-650 keV, 250-750 keV, 350-650 keV, 350-750 keV, 450-650 keV, and 450-750 keV, respectively. A lower energy level discriminator setting of 350 keV and 450 keV was used to assess the effect of 364 keV 131 I prompt emissions. An upper energy level discriminator setting of 750 keV was used to assess the effect of 637 keV 131 I prompt emissions. To estimate the prompt emission counting rate due to 131 I prompt emissions in GATE simulation, the output file was saved in ASCII format. The ASCII output file was an interfile with coded integers in 4 bytes without a header. The prompt emission counting rate due to 131 I prompt emissions was extracted from the ASCII file.
131 I Prompt Emission Fraction
When 18 F-FDG and 131 I were imaged simultaneously, 131 I prompt emission would contaminate 18 F-FDG PET images. The effect of count contamination due to 131 I prompt emission would escalate as 131 I activity increases. In this study, the 131 I prompt emission fraction was defined as " 131 I prompt emission / ( 18 F prompt + 131 I prompt emission)". The activity of 18 F-FDG was set to 100 µCi and the 131 I activities of 1 µCi, 10 µCi, 100 µCi to 1000 µCi (in steps of 100 µCi), and 10 mCi, were assessed.
Correction of 131 I Prompt Emission on 18 F-FDG PET Imaging
The distribution of 131 I prompt gamma was nearly uniform because the angle of emission of the prompt gamma was uncorrelated with the angle of the annihilation photons [21, 22] . For the correction of 131 I prompt gamma, first, the scatter sinogram was generated using a single scatter simulation scatter correction algorithm [23] . The edge of the scatter sinogram was identified by thresholding. The data outside the body was then calculated. 131 I prompt gamma was calculated using following equation. 131 I prompt gamma signogram = scatter sinogram × scale factor (1) where scale factor = 131 I prompt emission fraction. The prompt gamma and scatter distributions were subtracted from the uncorrected sinogram. The 131 I prompt emission-corrected sinogram was reconstructed with correction processes, such as attenuation, scatter, deadtime correction, and normalization. The rebinning and reconstruction were performed using the IAW program (ver. 1.4.3.6) provided by Siemens (Erlangen, Bavaria, Germany).
Phantom Study (Spill-Over Ratio)
131 I prompt emission-correction was applied to a phantom image. A NEMA NU4-2008 image-quality phantom was used to validate the prompt emission-photon correction. The activities were 1 mCi for 131 I and 100 µCi for 18 F-FDG. PET data were acquired for 20 min of emission and 15 min of transmission using an INVEON PET scanner. Transmission data were acquired using a 57 Co source within an energy window of 120-125 keV. The energy window of the emission scan was 350-650 keV. PET data were reconstructed with filtered back-projection (FBP) algorithms. To assess the effect of 131 I prompt emission-correction, image quality was assessed in terms of the spill-over ratio (SOR) according to the NEMA NU4-2008 guidelines. The SOR was defined as the ratio between the mean value of a cold cylinder and the mean value of the uniform area. The upper part of the uniform region was a cold region consisting of two empty cylinders (length: 15 mm, inner diameter: 8 mm, outer diameter: 10 mm). One space was filled with air and the other space with nonradioactive water. To calculate the SOR, 2 cylindrical VOIs (length: 7.5 mm, diameter: 4 mm) were drawn in the air-and water-filled compartments. We compared the SOR before and after prompt emission-photon correction. For the phantom study, we compared the results of pre-and post-131 I prompt emission fraction correction for a NEMA NU4-2008 image quality phantom [24] . To calculate the SOR, the volumes of interest (VOIs) were drawn on the nonradioactive region using a diameter 75% of that of the nonradioactive region. PET data were reconstructed using FBP. Normalization, dead-time, attenuation and scatter corrections have been applied to all PET raw data. However, partial volume correction was not applied during measurement of SOR because diameter of water filled-and air filled cylinder was relatively large (length: 15 mm, inner diameter: 8 mm, outer diameter: 10 mm) to avoid the partial volume effect.
In Vivo Study
Lymphoma Animal Model
We applied our developed prompt emission-photon-correction method to a mouse lymphoma model. To generate the mouse lymphoma model, human Burkitt CD20+ (Raji) cells were obtained from the American Type Culture Collection (Manassas, VA, USA), and maintained in roswell park memorial istitute (RPMI) medium containing 10% fetal bovine serum and antibiotics (Sigma, St Louis MO, USA). Cells were kept at 37 • C in a humidified 5% CO 2 incubator. Raji cells (1 × 10 7 ) were subcutaneously injected into female NOD/SCID mice (n = 10) (Animal Resource Centre, Murdoch, WA, Australia). The tumor volume was calculated using the formula (width 2 × length × 0.4).
Preparation of 131 I Rituximab
Precoated iodination tubes (Thermo Scientific, Waltham, MA, USA) were used for preparing 131 I rituximab for treating the lymphoma model mice. For radiolabeling, the Pierce precoated iodination tube was wet with 1 mL Tris iodination buffer, which was then again decanted, after which 60 µL (1.0 mCi) of 131 I was added to the iodination tube. Iodide was activated for 6 min at room temperature, then, 200 µg of rituximab was added and reacted with the iodide for 6-9 min at room temperature. Instant thin-layer chromatography (solvent: 100% acetone, C 3 H 6 O) showed that 131 I rituximab had a radiochemical purity >95%.
PET Imaging of Lymphoma Mouse Model
After confirmation of the 131 I rituximab uptake to tumor region, we made additional lymphoma tumor model (n = 5). When the tumor size reached 300 mm 3 , an 18 F-FDG PET scan of the lymphoma model was acquired as a gold standard to assess the standard uptake value (SUV) before administration of 131 I rituximab. After 10 half-lives of 18 F-FDG, 131 I rituximab was administered intravenously. After 48 h, 18 F-FDG PET was acquired. The activity of 131 I rituximab was 300 µCi/75 mg. The activity of 18 F-FDG was 100 µCi. PET data was reconstructed using FBP. The 131 I prompt emission-correction was applied to the data. All corrections, such as attenuation correction, scatter correction, dead-time correction, and normalization was performed. To assess the effect of 131 I prompt emission, an ROI (20-30 mm 2 ) was drawn on the tumor region in reconstruction trans-axial PET images both before and after 131 I prompt emission-correction. Contrast was also assessed within the tumor region. An ROI was drawn on the necrotic area in a cold region and on the tumor area in a hot region. Contrast was defined as the SUV of the hot region/the SUV of the cold region. The maximal value of SUV was measured for minimizing partial volume effect.
Results
The GATE code for the Inveon PET scanner simulation was modelled in our previous study [25] . The photoelectric effect, as well as Compton and Rayleigh interactions, were modelled. Energy cuts were performed on all simulated models. Energy blurring was set to 11% resolution. All physical processes of emission and interaction for 131 I and 18 F point sources were simulated. Figure 2 shows the Monte Carlo simulation result of the prompt emission counting rate for 131 I during PET scans using various PET energy windows. Although the prompt emission counting rate at 300 µCi 131 I was <15 kcps, the prompt emission counting rate reached 149 kcps and 10,117 kcps (not shown in graph) when the activity was 1000 µCi and 10,000 mCi 131 I, respectively, within a window of 350-650 keV. However, the prompt emission counting rate, even at 1000 µCi 131 I was nearly 0 (2 cps) within a window of 450-650 keV. This result demonstrated that 364 keV and 637 keV of a prompt emission-photon from 131 I was not influential within the 450-650 keV windows. Figure 3 shows the prompt emission counting rate for 18 F. Activities were set to 1, 10, 100, 100, and 10,000 µCi. A lower energy level discriminator setting of 350 keV and 450 keV was used to assess the effect of 364 keV of 131 I prompt emission. An upper energy level discriminator setting of 650 keV and 750 keV was used to assess the effect of 637 keV and 723 keV of 131 I prompt emission. Although the prompt emission counting rate at 300 µCi of 131 I was <15 kcps, the coincidence reached 157 kcps and 10 Mcps when the activity was 1 mCi and 10 mCi of 131 I within 350-650 keV, respectively. However, the coincidence rate with 300 µCi 131 I was nearly 0 (2 cps) within the 450-650 keV window. This demonstrated that the 131 I prompt emission at 364 keV and 637 keV had been discarded within the 450-650 keV window. Table 1 and Figure 4 shows the 131 I prompt emission fraction within various energy windows. Figure 4D shows that, within a 350-650 keV window, the 131 I prompt emission fraction was 12% when 300 µCi 131 I and 100 µCi 18 Figure 3A . Activities were set to 1, 10, 100, 100, 10,000 µCi. To correct 131 I prompt emission, we applied our developed 131 I prompt emission-correction method to both a phantom and an in vivo mouse lymphoma model. Figure 5A shows the representative PET image of NEMA NU4-2008 image quality phantom and Figure 5B shows the SOR results compared with the gold standard ( 18 F-FDG), before 131 I prompt emission and after 131 I prompt emission. SOR was 13.7% for 18 F-FDG PET. After administration of 131 I, SOR was 16.9% and 14.4% before and after 131 I prompt emission correction, respectively. The percentage difference was <5% between 18 F-FDG only and after 131 I prompt emission-correction.
When our 131 I prompt emission-correction method was applied to the in vivo mouse model (shown in Figure 5C ), the SUV of the tumor region was 2.74 ± 0.13 for 18 F-FDG PET only, 2.97 ± 0.18 after 131 I prompt emission-correction, and 3.78 ± 0.2 before 131 I prompt emission-correction (shown in Figure 5D . Contrast was improved by 18% after 131 I prompt emission-correction. Before 131 I prompt emission-correction, SUV was overestimated by 38% (* p < 0.05). However, there was no statistically significant difference between SUV for 18 F-FDG and after correction of 131 I prompt emission. To correct 131 I prompt emission, we applied our developed 131 I prompt emission-correction method to both a phantom and an in vivo mouse lymphoma model. Figure 5A shows the representative PET image of NEMA NU4-2008 image quality phantom and Figure 5B shows the SOR results compared with the gold standard ( 18 F-FDG), before 131 I prompt emission and after 131 I prompt emission. SOR was 13.7% for 18 F-FDG PET. After administration of 131 I, SOR was 16.9% and 14.4% before and after 131 I prompt emission correction, respectively. The percentage difference was <5% between 18 F-FDG only and after 131 I prompt emission-correction. 
Discussion
Prompt correction method of nonpure positron emitters including 82 Rb [21, 22] , 124 I [18, 26, 27] , 76 Br [28, 29] , and 86 Y [29] were introduced. This prompt gamma can directly contribute or indirectly scatter When our 131 I prompt emission-correction method was applied to the in vivo mouse model (shown in Figure 5C ), the SUV of the tumor region was 2.74 ± 0.13 for 18 F-FDG PET only, 2.97 ± 0.18 after 131 I prompt emission-correction, and 3.78 ± 0.2 before 131 I prompt emission-correction (shown in Figure 5D . Contrast was improved by 18% after 131 I prompt emission-correction. Before 131 I prompt emission-correction, SUV was overestimated by 38% (* p < 0.05). However, there was no statistically significant difference between SUV for 18 F-FDG and after correction of 131 I prompt emission.
Prompt correction method of nonpure positron emitters including 82 Rb [21, 22] , 124 I [18, 26, 27] , 76 Br [28, 29] , and 86 Y [29] were introduced. This prompt gamma can directly contribute or indirectly scatter down into the primary energy window [26] . The high energy of gammas can cause down scatter issues within the energy window of the 511 keV annihilation photons of PET imaging. We investigated whether low energy due to 131 I could also contaminate 18 F-FDG PET scans. We found count contamination on 18 F-FDG follow-up scans due to 131 I spill-over count after 131 I rituximab tumor targeted therapy. For this reason, we developed a PET image correction method to address the inclusion of 131 I during 18 F-FDG PET scans. When our developed method was applied to the measurement of SOR using the NEMA NU4 image quality phantom, 131 I prompt correction provided the similar level of SOR (the percentage difference was <5% between 18 F-FDG only and after 131 I prompt emission-correction). When our 131 I prompt emission-correction method was applied to the in vivo mouse model, the SUV of the tumor region was 2.74 ± 0.13 for 18 F-FDG PET only, 2.97 ± 0.18 after 131 I prompt emission-correction, and 3.78 ± 0.2 before 131 I prompt emission-correction. We found that our developed 131 I prompt correction method was applicable for both phantom and actual mouse study. Our 131 I prompt emission-correction method increased accuracy during measurement of standard uptake value on 18 F-FDG PET as well as spill-over ratio in phantom study.
We assessed the effect of 131 I in terms of SOR in a phantom and also applied it to a mouse model that had received 131 I rituximab. Our data showed that count contamination due to 131 I prompt emission was prominent when 131 I at higher activities was administered (at 10 mCi 131 I, the 131 I prompt emission fraction reached 99%). In addition, we found that there was a negligible effect of 131 I prompt emission within an energy window of 450-650 keV. Therefore, this energy window would be useful for 18 F-FDG follow-up scans. However, in a narrow energy window, such as 450-650 keV, the sensitivity would be significantly decreased when the conventional 350-650 keV energy window is used in a preclinical study. According to our Monte Carlo simulation study for the Inveon PET scanner, the sensitivities were 7.0% for 350-650 keV, 7.3% for 350-750 keV, 5.8% for 450-650 keV, and 6.0% for 450-750 keV windows. The sensitivity within the 450-650 keV window was degraded by 26% as compared to that of the 350-650 keV window. Decreased sensitivity in a PET scan indicates a decreased signal-to-noise ratio in PET. Therefore, there was a trade-off between count contamination due to 131 I prompt emissions and the signal-to-noise ratio between a narrow energy window (450-650 keV) and the conventional energy window (350-650 keV) in 18 F-FDG PET after 131 I administration. With application of our 131 I prompt correction method, a wider energy window, such as 350-650 keV would be advantageous over a 450-650 keV energy window.
The main limitation of this study was, given that our developed method was applicable to animal study, we used a wide energy window during PET scanning to improve sensitivity. However, narrower energy windows are typically used in a clinical setting and a low energy of 131 I would be negligible during 18 F-FDG scanning. In summary, although these findings have a limited application for clinical use, our developed method could be feasible in animal studies, especially in 18 F-FDG PET assessment of the therapeutic efficacy of RIT, such as 131 I rituximab.
Conclusions
In conclusion, we developed an 131 I prompt emission-correction method for 18 F-FDG PET imaging after 131 I rituximab therapy and applied it to an in vivo mouse model. Our method will facilitate
